Celularity Inc., (CELU) Social Stream
Celularity Inc (CELU) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CELU.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 2 | $16 | $10 | $13 | $8.88 | 46.4% |
| 2021-12-10 | 3 | $16 | $9 | $11.666 | $8.88 | 31.37% |
| 2022-01-28 | 4 | $16 | $9 | $11 | $8.88 | 23.87% |
| 2022-01-31 | 4 | $16 | $8 | $10.75 | $8.88 | 21.06% |
| 2022-03-31 | 3 | $10 | $8 | $9 | $8.88 | 1.35% |
The Trend in the Analyst Price Target
Over the past 62 days, CELU's average price target has gone down $2.
Over the past 34 weeks, CELU's average upside potential has been 113.22%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-18 | NA | 16 | 16 | 16.00 | 6.24 | 156.41% |
| 2021-09-19 | NA | 16 | 16 | 16.00 | 6.24 | 156.41% |
| 2022-01-31 | 3 | 16 | 8 | 10.75 | 4.50 | 138.89% |
| 2022-01-31 | 4 | 16 | 8 | 10.75 | 4.50 | 138.89% |
| 2022-01-31 | 4 | 10 | 8 | 9.00 | 4.50 | 100% |
CELU Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 59 days, CELU's average broker recommendation rating worsened by 0.17.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Celularity Inc fares relative to all US stocks, note that its average analyst price target is higher than 75.71% of that group.
- Celularity Inc's number of analysts covering the stock is greater than 95.37% of all US stocks.
- Celularity Inc's upside potential (average analyst target price relative to current price) is greater than 99.12% of Pharmaceutical Products stocks.
- In the context of stocks in the small market cap category, Celularity Inc's variance in analysts' estimates is lower than -368.47% of them.
In the Pharmaceutical Products industry, CDMO, CBIO, and CBAY are the three stocks most similar to Celularity Inc regarding the price target and analyst recommendation information presented here.
Is CELU a Buy, Hold or Sell? See the POWR Ratings now!